logo

MEDICO vs THEMISMED: Stock Comparison

MEDICO REMEDIES vs THEMIS MEDICAREUpdated 22 Oct 26, 4:08 PM ISTNSE & company filings

THEMIS MEDICARE is the larger company by market capitalisation. MEDICO REMEDIES shows a higher ROE, faster revenue growth and lower leverage, while THEMIS MEDICARE shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

MEDICO leads 7; THEMISMED leads 4 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

MEDICOTHEMISMED

Valuation lens

What price are you paying?

Market CapContext only
₹169 Cr
₹857 Cr
P/E RatioTHEMISMED has the lower reading
26.66x
23.09x ✓
P/B RatioTHEMISMED has the lower reading
4.86x
2.32x ✓
EPSTHEMISMED has the higher reading
₹0.3
₹2.67 ✓
Book ValueContext only
₹9.1
₹43.28
Dividend YieldTHEMISMED has the higher reading
0%
0.52% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
THEMISMED is the larger company
₹857 Cr vs ₹169 Cr
P/E Ratio
THEMISMED has a lower P/E
23.09x vs 26.66x
P/B Ratio
THEMISMED has a lower P/B
2.32x vs 4.86x
EPS
THEMISMED has higher earnings per share
₹2.67 vs ₹0.3
Dividend Yield
THEMISMED has a higher dividend yield
0.52% vs 0%
Revenue Growth (TTM YoY)
MEDICO has faster revenue growth
37.5% vs 6.7%
EPS Growth (TTM YoY)
MEDICO has faster EPS growth
36.5% vs 0%
ROE
MEDICO has a higher ROE
17.38% vs -4.71%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricMEDICOTHEMISMED
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricMEDICOTHEMISMED
Live Price₹20.5₹94.59
Day Change-1.35%-1.36%
Volume64,95148,840
52-Week High₹56.88₹140.6
52-Week Low₹20.47₹64.95
Distance from 52W High-63.96%-32.72%

Valuation

MetricMEDICOTHEMISMED
Market Cap₹169 Cr₹857 Cr
P/E Ratio26.66x23.09x
P/B Ratio4.86x2.32x
EPS₹0.3₹2.67
Book Value₹9.1₹43.28
Dividend Yield0%0.52%

Growth

MetricMEDICOTHEMISMED
Revenue Growth (TTM YoY)37.5%6.7%
EPS Growth (TTM YoY)36.5%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricMEDICOTHEMISMED
ROE17.38%-4.71%
ROCE15.14%-0.63%
Net Margin6.36%0.33%
Operating Margin9.63%-0.79%
Debt to Equity0.25x0.33x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricMEDICOTHEMISMED
Promoter Holding61.38%57.5%
FII Holding0.6%▲ 0.52 pp0.01%▼ 0.1 pp
DII Holding0%0.01%
Public Holding38.02%▼ 0.52 pp32.87%▲ 0.09 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: MEDICO REMEDIES and THEMIS MEDICARE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.